Inclusion of Demographic-Specific Information in Studies Supporting US Food & Drug Administration Approval of High-Risk Medical Devices

Παρόμοια τεκμήρια

• Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements
  ανά: Zheng, Sarah Y., κ.ά.
  Έκδοση: (2017)
• Assessment of Clinical Trial Evidence for High-Risk Cardiovascular Devices Approved Under the Food and Drug Administration Priority Review Program
  ανά: Jones, L. Camille, κ.ά.
  Έκδοση: (2018)
• Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death
  ανά: Lalani, Christina, κ.ά.
  Έκδοση: (2021)
• Comparison of Priority vs Standard US Food and Drug Administration Premarket Approval Review for High-Risk Medical Devices
  ανά: Ong, Caroline, κ.ά.
  Έκδοση: (2020)
• Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the De Novo Pathway Between 2011 and 2019
  ανά: Johnston, James L., κ.ά.
  Έκδοση: (2020)